Table of contents
QuickSTAT leverages digital tools and deep industry expertise to successfully manage the complexities of delivering cell and gene therapy (C>).
Key Topics:
- Outsourcing logistics for time-sensitive therapies.
- Using real-time data to mitigate risks in global supply chains.
- Ensuring visibility across unique delivery locations and geographies.
- Leveraging digitalization to meet the challenges of cell and gene therapy logistics.
Michael Sweeney, Global Head of Strategy at QuickSTAT, discusses critical challenges and innovations in cell and gene therapy logistics—from ensuring seamless communication with hospitals and drivers, to using real-time data to navigate global supply chain risks. This episode dives deep into how digitalization drives visibility, proactive risk management, and trust in one of healthcare’s most demanding supply chains. Watch Part 2 now and be sure to watch Part 1, if you missed it.
Video Highlights:
- 00:50 - What is QuickSTAT's approach to outsourcing, and what are the related digitalization challenges?
- 04:05 - How is visibility ensured across unique pick-up and drop-off locations?
- 11:35 - How do you ensure readiness when things take an unexpected turn?
- 15:45 - Is there an opportunity to harmonize product movement data?
- 19:35 - How does QuickSTAT leverage the broad network of its parent company, Kuehne+Nagel?
